Sun Pharma to buy remaining stake in Israeli unit Taro for about $348 million

Sun Pharma#39;s offer amounts to about $347.8 million, as per Reuters calculations, with the per share value at a 4.2% premium to Taro#39;s close on Wednesday.

Top 100 Best Sellers

Read More

​ Sun Pharma#39;s offer amounts to about $347.8 million, as per Reuters calculations, with the per share value at a 4.2% premium to Taro#39;s close on Wednesday. Sun Pharma#39;s offer amounts to about $347.8 million, as per Reuters calculations, with the per share value at a 4.2% premium to Taro#39;s close on Wednesday.  Moneycontrol Latest News Read More